This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
What's in the Offing for Gen Digital (GEN) in Q4 Earnings?
by Zacks Equity Research
Post the acquisition, the integration of Avast Plc is likely to have driven Gen Digital's (GEN) Q4 top line. However, the equity dilution impact of the same acquisition is anticipated to have weighed on the EPS.
Gen Digital (GEN) Tops on Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital's (GEN) Q3 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Gen Digital (GEN) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Gen Digital (GEN) delivered earnings and revenue surprises of 7.14% and 0.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Gen Digital (GEN) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Gen Digital's (GEN) Q3 top line is likely to have benefited from the inclusion of the Avast business. However, the equity dilution impact of the Avast acquisition is anticipated to have weighed on EPS.
Do Options Traders Know Something About Gen Digital (GEN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Gen Digital (GEN) stock based on the movements in the options market lately.
NortonLifeLock (GEN) Down 1.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
NortonLifeLock (GEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Gen Digital, ADT and KnowBe4
by Zacks Equity Research
Gen Digital, ADT and KnowBe4 have been highlighted in this Industry Outlook article.
3 Security and Safety Services Stocks to Beat Industry Woes
by Eshani Haque
Supply chain woes and cost inflation weigh on the Zacks Security and Safety Services industry's near-term prospects. However, GEN, ADT and KNBE are set to benefit from continued demand, product upgrades and digitization.
Gen Digital (GEN) Gains on Q2 Earnings Meet, Revenue Beat
by Zacks Equity Research
Gen Digital's (GEN) Q2 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Ensign Group (ENSG) Continues to Gain From Buyout Binge
by Zacks Equity Research
Ensign Group's (ENSG) series of buyouts poise it well for growth by enhancing its capabilities, both financially and clinically.
Genesis Healthcare Enters Oversold Territory
by Zacks Equity Research
Genesis Healthcare has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
HCA Healthcare Plunges Above 39% Year to date: Here's Why
by Zacks Equity Research
HCA Healthcare (HCA) stock plunges due to halt in elective surgeries, exorbitant costs and an escalating leverage level.
Brookdale Scraps Earnings View Due to COVID-19 Uncertainty
by Zacks Equity Research
Brookdale (BKD) pulls down 2020 earnings guidance, takes steps to preserve liquidity and incurs additional cost for prevention measures.
Ensign Group Expands Colorado Presence With Twin Buyouts
by Zacks Equity Research
Ensign Group (ENSG) continues with its buyout binge by acquiring nursing facilities in Colorado.
Ensign Acquires Healthcare Center, Buyout Spree Continues
by Sapna Bagaria
The acquisition of Healthcare Center adds to Ensign Group's (ENSG) portfolio of skilled nursing and independent living services.
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
On the back of its restructuring initiatives and solid membership, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Ensign Group (ENSG) Takes Shareholder-Friendly Initiatives
by Zacks Equity Research
Ensign Group (ENSG) clears a quarterly dividend hike to share more profits with investors.
Tenet Healthcare to Divest Units for Streamlining Operations
by Zacks Equity Research
Tenet Healthcare (THC) to sell its Memphis area units for clearing its debt and focusing on core business.
Tenet Healthcare Soars 117.1% YTD: Will Growth Continue?
by Zacks Equity Research
Tenet Healthcare's (THC) partnerships and acquisitions are likely to continue boosting its revenue base, which in turn, might perk up its share price.
Humana's (HUM) Alliances to Offer Relief to Members With CKD
by Zacks Equity Research
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on a growing top line and higher membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting
5 Top Stocks to Buy on Blockbuster Jobs Data
by Zacks Equity Research
U.S. non-farm payroll data for November shows that job creation hasn't slowed but has shown signs of reacceleration. Here are five stocks from the best-performing sectors.
Ensign Group (ENSG) on Buyout Binge to Boost Capabilities
by Zacks Equity Research
Ensign Group's (ENSG) acquisition spree in Texas and Arizona will enhance its portfolio and better serve the local communities.
Here's Why Should You Hold MEDNAX (MD) in Your Portfolio
by Zacks Equity Research
Riding high on its solid top line as well as strategic buyouts, MEDNAX (MD) holds enough potential to generate returns for investors.